ATYPICAL CHRONIC MYELOID LEUKEMIA
Clinical trials for ATYPICAL CHRONIC MYELOID LEUKEMIA explained in plain language.
Never miss a new study
Get alerted when new ATYPICAL CHRONIC MYELOID LEUKEMIA trials appear
Sign up with your email to follow new studies for ATYPICAL CHRONIC MYELOID LEUKEMIA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for toughest blood cancers: scientists tweak transplant drugs to fight disease and spare patients
Disease control Recruiting nowThis study aims to improve outcomes for patients with high-risk blood cancers who receive a stem cell transplant from a partially matched donor. Researchers are testing a modified combination of two drugs (bendamustine and cyclophosphamide) given after the transplant. The goal is…
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE2 • Sponsor: St. Petersburg State Pavlov Medical University • Aim: Disease control
Last updated Mar 31, 2026 12:10 UTC
-
New drug combo tested for Tough-to-Treat blood cancers
Disease control Recruiting nowThis study is testing a new combination of two drugs, axatilimab and azacitidine, for people with advanced or hard-to-treat blood cancers. The first part of the study aims to find the safest and most effective dose. The second part will see how well the drug combination works to …
Matched conditions: ATYPICAL CHRONIC MYELOID LEUKEMIA
Phase: PHASE1, PHASE2 • Sponsor: Uma Borate • Aim: Disease control
Last updated Mar 24, 2026 12:02 UTC